Pilloxa
- hard tech
- horizon europe
- woman founder
- spinout
- eit ecosystem
- eit health
- tech for patients
- digital care
- eit supernovas
- research and development
- headstart (eit health)
- clinical trials
- health information
- investor network (eit health)
- medication adherence
- investor network 2019 (eit health)
- headstart 2018 (eit health)
- start-ups meet pharma (eit health)
- product market fit (eit health)
- start-ups meet pharma 2019 (eit health)
- product market fit 2017 (eit health)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m | <1m |
% growth | - | 589 % | 106 % | 72 % | 105 % | (37 %) |
EBITDA | - | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
% EBITDA margin | - | (1216 %) | (773 %) | (913 %) | (483 %) | (619 %) |
Profit | <1m | (<1m) | (<1m) | (<1m) | (<1m) | (<1m) |
% profit margin | 100 % | (1336 %) | (953 %) | (1057 %) | (557 %) | (733 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | €260k | Seed | |
N/A | SEK5.6m | Early VC | |
€50.0k | Grant | ||
€10.0k | Grant | ||
$1.3m | Early VC | ||
* | SEK30.0m Valuation: SEK30.0m 50.0x EV/LTM Revenues -8.1x EV/LTM EBITDA | Acquisition | |
Total Funding | AUD3.6m |
Related Content
Recent News about Pilloxa
EditPilloxa operates in the healthcare technology sector, providing a platform designed to enhance patient engagement and adherence to treatment plans. The company primarily serves healthcare providers, pharmaceutical companies, and clinical researchers who aim to improve patient outcomes through digital solutions. Pilloxa's core product is a customizable, branded mobile application that helps patients stay on top of their medication schedules and treatment plans. The app collects real-time data and insights, allowing healthcare providers to monitor patient adherence and make data-driven decisions to optimize treatment effectiveness.
The business model is based on a standardized flat fee pricing structure, ensuring transparency and predictability in costs. Clients pay for the services they use, with no hidden fees, making it an attractive option for budget-conscious healthcare organizations. The platform also offers fast initiation, with standardized legal and regulatory documentation, enabling clients to get their app programs up and running within a month.
Pilloxa generates revenue through subscription fees from healthcare providers and pharmaceutical companies who use their platform to engage patients and gather valuable insights. The company differentiates itself by focusing on patient value, ensuring all patient functionalities are included and continuously adding new features to enhance the user experience.
Keywords: patient engagement, treatment adherence, healthcare technology, real-time insights, branded apps, pharmaceutical companies, clinical researchers, digital health, data-driven decisions, subscription fees.